OSE Immunotherapeutics Statistics

Total Valuation

LON:0RAD has a market cap or net worth of GBP 129.84 million. The enterprise value is 103.50 million.

Market Cap	129.84M
Enterprise Value	103.50M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+22.97%
Shares Change (QoQ)	+22.87%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	16.45M

Valuation Ratios

The trailing PE ratio is 3.33.

PE Ratio	3.33
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.33, with an EV/FCF ratio of 2.09.

EV / Earnings	2.65
EV / Sales	1.50
EV / EBITDA	2.33
EV / EBIT	2.33
EV / FCF	2.09

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.54.

Current Ratio	4.93
Quick Ratio	4.70
Debt / Equity	0.54
Debt / EBITDA	0.82
Debt / FCF	0.75
Interest Coverage	18.48

Financial Efficiency

Return on equity (ROE) is 88.54% and return on invested capital (ROIC) is 35.12%.

Return on Equity (ROE)	88.54%
Return on Assets (ROA)	30.41%
Return on Invested Capital (ROIC)	35.12%
Return on Capital Employed (ROCE)	43.58%
Revenue Per Employee	1.36M
Profits Per Employee	750,516
Employee Count	55
Asset Turnover	0.75
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +100.83% in the last 52 weeks. The beta is 0.96, so LON:0RAD's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+100.83%
50-Day Moving Average	7.06
200-Day Moving Average	7.16
Relative Strength Index (RSI)	55.82
Average Volume (20 Days)	352

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RAD had revenue of GBP 70.74 million and earned 39.03 million in profits. Earnings per share was 1.71.

Revenue	70.74M
Gross Profit	70.74M
Operating Income	45.65M
Pretax Income	41.91M
Net Income	39.03M
EBITDA	44.90M
EBIT	45.65M
Earnings Per Share (EPS)	1.71

Full Income Statement

Balance Sheet

The company has 64.22 million in cash and 37.21 million in debt, giving a net cash position of 27.01 million.

Cash & Cash Equivalents	64.22M
Total Debt	37.21M
Net Cash	27.01M
Net Cash Per Share	n/a
Equity (Book Value)	69.05M
Book Value Per Share	3.17
Working Capital	57.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 49.48 million and capital expenditures -28,826, giving a free cash flow of 49.45 million.

Operating Cash Flow	49.48M
Capital Expenditures	-28,826
Free Cash Flow	49.45M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 64.52% and 55.17%.

Gross Margin	100.00%
Operating Margin	64.52%
Pretax Margin	59.25%
Profit Margin	55.17%
EBITDA Margin	63.46%
EBIT Margin	64.52%
FCF Margin	69.90%

Dividends & Yields

LON:0RAD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.97%
Shareholder Yield	-22.97%
Earnings Yield	30.06%
FCF Yield	38.08%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RAD has an Altman Z-Score of 3.94.

Altman Z-Score	3.94
Piotroski F-Score	n/a